Characterization of Patients with Ankylosing Spondylitis Receiving Secukinumab and Reasons for Initiating Treatment: A US Physician Survey and Retrospective Medical Chart Review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-9788
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characterization of Patients with Ankylosing Spondylitis Receiving Secukinumab and Reasons for Initiating Treatment: A US Physician Survey and Retrospective Medical Chart Review ; day:7 ; month:1 ; year:2019 ; pages:1-9
Drugs - real world outcomes ; (7.1.2019), 1-9
- Urheber
-
Joshi, Reeti
Latremouille-Viau, Dominick
Meiselbach, Mark K.
Xie, Jipan
Park, Yujin
Sunkureddi, Prashanth
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40801-018-0146-9
- URN
-
urn:nbn:de:101:1-2019021102252044142149
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Joshi, Reeti
- Latremouille-Viau, Dominick
- Meiselbach, Mark K.
- Xie, Jipan
- Park, Yujin
- Sunkureddi, Prashanth
- SpringerLink (Online service)
Ähnliche Objekte (12)
Secukinumab: A Review in Ankylosing Spondylitis
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective
Andersson lesion in ankylosing spondylitis
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis : results from phase IV ASTRUM study
Surgical treatment of ankylosing spondylitis deformity
Ankylosierende Spondylitis: Secukinumab lindert Fatigue schnell und anhaltend
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
ANKHvariants associated with ankylosing spondylitis: gender differences
Secukinumab: A Review in Ankylosing Spondylitis
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective
Andersson lesion in ankylosing spondylitis
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis : results from phase IV ASTRUM study
Surgical treatment of ankylosing spondylitis deformity
Ankylosierende Spondylitis: Secukinumab lindert Fatigue schnell und anhaltend
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
ANKHvariants associated with ankylosing spondylitis: gender differences
Secukinumab: A Review in Ankylosing Spondylitis
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective
Andersson lesion in ankylosing spondylitis
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis : results from phase IV ASTRUM study
Surgical treatment of ankylosing spondylitis deformity
Ankylosierende Spondylitis: Secukinumab lindert Fatigue schnell und anhaltend
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?